Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed attachment file name title question first answered answering member label
tabling member	label

Search

773568

registered interest
date	19/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to ensure that the families of children believed to have suffered serious adverse reactions to human papilloma virus vaccinations are treated with the same levels of dignity and respect accorded to families whose children have other medical conditions.
tabling member printed	The Countess of Mar
uin	HL2283
answer	answer is ministerial correction date of answer 01/11/2017 answer text <p>Anyone suffering ill health deserves access to appropriate clinical investigation and care, and to be treated with dignity and respect. This is an important responsibility of doctors and other healthcare providers.</p><p>The Medicines and Healthcare products Regulatory Agency takes every report of a suspected adverse reaction seriously and has closely evaluated the safety of the human papillomavirus vaccine since the vaccination programme was introduced in the United Kingdom in 2008. All reports, including any submitted by patients and their families, are kept under continual review to identify potential new risks.</p> answering member printed Lord O'Shaughnessy question first answered 01/11/2017 12:47:48 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1861 label Biography information for The Countess of Mar

600530

registered interest
date	12/10/2016
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Energy: Conservation
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what steps they are taking to fill senior management vacancies on the Energy Savings Opportunity Scheme.
tabling member printed	Lord Moonie
uin	HL2283
answer	answer is ministerial correction date of answer 19/10/2016 answer text <p>The Environment Agency (EA) has recently restructured its senior management team following a voluntary exit scheme and has filled all vacancies within the Energy Saving Opportunity Scheme (ESOS) senior team.</p> answering member printed Baroness Neville-Rolfe question first answered 19/10/2016 13:26:25 answering member 4284 label Biography information for Baroness Neville-Rolfe
tabling member	621 label Biography information for Lord Moonie

419210

registered interest
date	16/09/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what the Department of Health is doing to prioritise the availability of treatments for rare blood cancers, such as multiple myeloma.
tabling member printed	Lord Willis of Knaresborough
uin	HL2283
answer	answer is ministerial correction date of answer 22/09/2015 answer text <p>Ensuring that the National Health Service is able to support the availability and use of effective medicines for cancers, including rare blood cancer, is a key priority.</p><p> </p><p> </p><p> </p><p>Cancer 52, an organisation which specifically represents patients with rarer cancers, was represented on the independent Cancer Taskforce. The Taskforce published its report, <em>Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020</em>, in July, and made many recommendations relevant to rarer and blood cancers, focussing in particular on improving access to diagnostic testing, including fast, direct general practitioner access to key blood tests, and increasing patient access to the most advanced treatments. NHS England, Public Health England and other healthcare organisations are now considering the detail of the individual recommendations.</p><p> </p><p> </p><p> </p><p>Earlier in 2015, NHS England consulted on the principles and process by which it makes investment decisions in specialised services, which address the issue of rarity. The outcome of future investment decisions taken by NHS England will be published in accordance with the new process. NHS England’s response to the consultation is attached, and can be found at:</p><p> </p><p> </p><p> </p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/key-docs/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/key-docs/</a></p><p> </p><p> </p><p> </p><p> </p><p> </p><p>In addition to drug treatments for blood cancers, NHS England also commissions blood and bone marrow transplantation in accordance with its current published policy. A revision of the policy is planned during 2015-16 to be implemented during 2016-17. The current published policy is attached, and can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/04/b04-p-a.pdf" target="_blank">http://www.england.nhs.uk/wp-content/uploads/2013/04/b04-p-a.pdf</a></p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence is developing guidelines for the treatment of multiple myeloma and these are currently subject to public consultation.</p><p> </p> answering member printed Lord Prior of Brampton attachment 1 file name nhse-respns-publictn-17-06-15.pdf title NHS England consultation response 2 file name b04-p-a (1).pdf title Transplantation policy April 2013 question first answered 22/09/2015 10:22:16 answering member 127 label Biography information for Lord Prior of Brampton
tabling member	4151 label Biography information for Lord Willis of Knaresborough

100077

registered interest
date	21/10/2014
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	Pakistan
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is their assessment of the position of Ms Asia Bibi, a Christian mother of four sentenced to death in Lahore under Pakistan's blasphemy laws; and whether they intend to make representations to the government of Pakistan.
tabling member printed	Lord Patten
uin	HL2283
answer	answer is ministerial correction date of answer 04/11/2014 answer text We are concerned to hear that a Pakistan court has upheld the imposition of the death penalty in the case of Asia Bibi. We support the EU's recent statement of concern and hope that the verdict will be overturned on appeal. We regularly raise at the highest levels the misuse of blasphemy laws in Pakistan both against Muslims and against religious minorities. We have consistently pressed the Government of Pakistan on the issue of the death penalty and expressed our principled opposition to it in all cases. We will continue to raise these issues. answering member printed Baroness Anelay of St Johns question first answered 04/11/2014 17:14:45 answering member 3474 label Biography information for Baroness Anelay of St Johns
tabling member	1137 label Biography information for Lord Patten